Annual Full Year Report - My Estimate figures
Apart from the cash receipts - the other main items in operating costs I think can influence the bottom line
* salary
* share based payments
* tax benefits.
O = Projected increase in salary to more sale staff.
- = share based payments - should reduce their monetary paid - sp performance has been poor.
they need to stop giving options to their executive to buy at 3c /6c. RHT can buy back some of it shares - and give back to shareholders
<- = tax benefit can influence the bottom line.
Again - these figures are set already and will be past when the results are released.
For sp to move up - Need to look at their Strategy for Growth.
Annual Full Year Report - Strategy for Growth. My Expectation
Search for new distributors in Canada, UK, France, Germany, USA, Oz & NZ.
Hire specialists for each of these countries to build rapport and sign distribution contracts for usage of the AI software suite.
Yes - that will mean increase in salary costs - but who cares when RHT has no debt and sitting on $9m of cash doing crap all in the bank.
Increase the number of distributors from Siemens Healthcare GmbH and 3DR Laboratory Marketplace.
RHT need to capture min 2 new distributors to equate to similar usage size of Siemens and 3DR Lab, thereby increasing its sales receipts at a faster pace.
They also need to maintain the current two distributors but increase their usage of the FerriSmart AI suite and other add on products.
Also, 76% of sales revenue was derived from the usa and canada, with Uk contributing 18%. Therefore, he needs to focus on these 3 countries first. The balance came from europe, australia and middle east.
At June 2020 - RHT only had 55,000 FerriScan analyses usage - which are reimbursed by goverments in UK and Canada - and some private payer in USA.
Therefore I expect the new marketing guy to increase this number to 100,000 in UK and Canada as government are reimbursing for the clients - it will be easier to promote usage.
In the end, the market and investors alike only want to see one thing ---> a jump in cash receipts.
I give the new marketing guy 6 months to get himself in order and start signing contracts and establishing new networks.
The market - i think will only give him 3months - as he comes already with experiences and network in china and usa experiences.
Not sure - my forecast for the new marketing guy to achieve in the coming years wil be what the market is expecting.
This will equate into the different revenue streams:
The new marketing guy needs to focus on:
* Commerical revenue; and
* Clinical Trails - fees for data analytical services.
I think, if he really has the depth of experiences as mentioned above - I think my projected target is achieveable.
But RHT has never provided actual numbers in their growth strategy - so I dont know how the market will react to words and promises of growth only.
- Forums
- ASX - By Stock
- Ann: Appointment of GM - Global Sales & Marketing
Annual Full Year Report - My Estimate figuresApart from the cash...
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHT (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.75M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 81906 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 46106 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 81906 | 0.079 |
1 | 6840 | 0.077 |
1 | 26078 | 0.075 |
1 | 65000 | 0.073 |
1 | 68200 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 46106 | 2 |
0.083 | 80000 | 1 |
0.085 | 3708 | 1 |
0.086 | 34482 | 1 |
0.088 | 70446 | 1 |
Last trade - 16.12pm 07/05/2024 (20 minute delay) ? |
Featured News
RHT (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online